Vote Scores
Filings read through

NeoGenomics, Inc.: how funds voted at the meeting of 23 May 2024

Ticker
NEO
Meeting
Season
year to 30 June 2024
Filers reporting
440
Ballot items
5

440 filers on Form N-PX reported votes at the NeoGenomics, Inc. meeting of 23 May 2024. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of NeoGenomics, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    9 nominees. 86.5% of the reported votes are for. 81 filers withheld from or voted against at least one nominee.

    2,520 vote records from 153 filers. 1 of the 151 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 43 fund families
    • For 43
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    621 vote records from 431 filers. 231 of the 414 filers that marked the item voted against management. 17 filers gave no management mark.

    • Positions of 46 fund families
    • For 19
    • Against 27
    • Against management 27
  3. Item 3: Audit-related items (auditor ratification)

    279 vote records from 152 filers. 2 of the 150 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 43 fund families
    • For 43
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    36 vote records from 21 filers. 0 of the 20 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 6 fund families
    • For 6
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    253 vote records from 136 filers. 2 of the 135 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 39 fund families
    • For 39

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at NeoGenomics, Inc., meeting of 23 May 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinAgainst, against managementNo report
AllspringAgainst, against managementFor
American CenturyAgainst, against managementFor
BairdAgainst, against managementFor
BlackRock and iSharesForFor
BNY MellonAgainst, against managementFor
Brighthouse FundsAgainst, against managementFor
Charles SchwabForFor
Columbia ThreadneedleAgainst, against managementFor
DimensionalAgainst, against managementFor
DWSAgainst, against managementFor
EquitableForFor
Federated HermesForFor
FidelityForFor
First TrustAgainst, against managementFor
Franklin TempletonForFor
Global XForFor
Goldman SachsAgainst, against managementFor
Guggenheim and RydexAgainst, against managementFor
Hartford FundsAgainst, against managementFor
InvescoAgainst, against managementFor
J.P. MorganAgainst, against managementFor
Jackson National fundsAgainst, against managementFor
Janus HendersonForFor
John Hancock and ManulifeAgainst, against managementFor
Lincoln FinancialForFor
Macquarie and Delaware FundsAgainst, against managementFor
MassMutualAgainst, against managementFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementFor
NationwideAgainst, against managementFor
Natixis and Loomis SaylesForNo report
Neuberger BermanForNo report
Northern Trust and FlexSharesForFor
Nuveen and TIAAAgainst, against managementFor
Pacific Life fundsForFor
PGIM and PrudentialForFor
PrincipalForFor
ProShares and ProFundsAgainst, against managementFor
SEIForFor
State Street and SPDRForFor
T. Rowe PriceForFor
ThriventAgainst, against managementFor
TransamericaAgainst, against managementFor
VanguardForFor
Victory CapitalAgainst, against managementFor
VoyaAgainst, against managementFor

Questions

How many filers reported votes at the NeoGenomics, Inc. meeting?
440 Form N-PX filers reported votes at the meeting of 23 May 2024. On say-on-pay, 231 of 414 filers that marked the item voted against management (55.8%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. NeoGenomics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list NeoGenomics, Inc. with a meeting date within three days of 23 May 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .